Pluvia Biotech
Pluvia Biotech is a spin-out from the University of Bergen (Norway) dedicated to developing "first in class" oral pharmacological chaperones for the treatment of Phenylketonuria (PKU). Through pioneering research and development, Pluvia Biotech aims to provide PKU patients with the opportunity to live life without the dietary constraints imposed by the condition. The company has significant momentum moving its lead compound towards clinical Proof of Concept.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
9
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Pluvia Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- AK
Ann Kari Grindheim
Director, Non-clinical Development · General Business & Management
EmailPhone - AA
Altanchimeg Altankhuyag
Senior Researcher · Science
EmailPhone - KS
Karina S. Prestegård
Senior Scientist · Research & Development
EmailPhone - RE
Randi Elisabeth Taxt
Styremedlem · General Business & Management
EmailPhone
Showing 4 of 5 verified contacts
Top roles at Pluvia Biotech
4 distinct titles indexed · top 4 shown.
- 1director, non-clinical development
- 1senior researcher
- 1senior scientist
- 1styremedlem
Sign up to unlock all 5 contacts at Pluvia Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Pluvia Biotech
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.